JPH0331226B2 - - Google Patents

Info

Publication number
JPH0331226B2
JPH0331226B2 JP57187625A JP18762582A JPH0331226B2 JP H0331226 B2 JPH0331226 B2 JP H0331226B2 JP 57187625 A JP57187625 A JP 57187625A JP 18762582 A JP18762582 A JP 18762582A JP H0331226 B2 JPH0331226 B2 JP H0331226B2
Authority
JP
Japan
Prior art keywords
antibody according
iodothyronine
thyroxine
iodine
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57187625A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5888660A (ja
Inventor
Hooru Arubarera Jeemuzu
Josefu Kyariko Robaato
Emu Rii Toomasu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Inc filed Critical Miles Inc
Publication of JPS5888660A publication Critical patent/JPS5888660A/ja
Publication of JPH0331226B2 publication Critical patent/JPH0331226B2/ja
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP57187625A 1981-11-04 1982-10-27 ヨードチロニン免疫複合体に対する抗体 Granted JPS5888660A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US318026 1981-11-04
US06/318,026 US4358604A (en) 1981-11-04 1981-11-04 N-Aminoalkyl iodothyronine derivatives
US363084 1982-03-29

Publications (2)

Publication Number Publication Date
JPS5888660A JPS5888660A (ja) 1983-05-26
JPH0331226B2 true JPH0331226B2 (enExample) 1991-05-02

Family

ID=23236314

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57187625A Granted JPS5888660A (ja) 1981-11-04 1982-10-27 ヨードチロニン免疫複合体に対する抗体

Country Status (2)

Country Link
US (1) US4358604A (enExample)
JP (1) JPS5888660A (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399121A (en) * 1981-11-04 1983-08-16 Miles Laboratories, Inc. Iodothyronine immunogens and antibodies
US4670406A (en) * 1984-01-06 1987-06-02 Becton Dickinson And Company Tracers for use in assays
US4591569A (en) * 1984-04-11 1986-05-27 Becton Dickinson & Company Homogeneous fluorescent triiodothyronine uptake test
DE3628795A1 (de) * 1986-08-25 1988-03-03 Hoechst Ag Neue thyroninderivate
US6716452B1 (en) * 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6627660B1 (en) * 1999-11-16 2003-09-30 New River Pharmaceuticals Inc. Stabilized thyroxine compounds
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US20060014697A1 (en) 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2680762A (en) * 1949-09-08 1954-06-08 Glaxo Lab Ltd Preparation of 2:6-diiododiphenyl ethers
US3045041A (en) * 1960-07-18 1962-07-17 Univ California Naphthoxy substituted phenylalanine derivatives
GB1047082A (en) * 1963-02-01 1966-11-02 Pfizer & Co C Thyronine derivatives
US3714241A (en) * 1969-10-29 1973-01-30 Merck & Co Inc PREPARATION OF alpha -METHYL-3,4-DISUBSTITUTED PHENYLALANINES
US4171432A (en) * 1978-06-22 1979-10-16 Miles Laboratories, Inc. Flavin adenine dinucleotide-iodothyronine conjugates
US4311853A (en) * 1979-02-06 1982-01-19 The Radiochemical Centre Limited Selenium derivatives of thyroxine and tri-iodothyronine

Also Published As

Publication number Publication date
US4358604A (en) 1982-11-09
JPS5888660A (ja) 1983-05-26

Similar Documents

Publication Publication Date Title
EP0078952B1 (en) N-aminoalkyl iodothyronine derivatives, iodothyronine immunogens and antibodies
JP5031585B2 (ja) ５−フルオロ−ウラシル免疫測定法
JPS5928864B2 (ja) バルビツ−ル酸抗原およびそれに対して特異な抗体
JPH07505634A (ja) 新規オピエート誘導体，タンパクおよびポリペプチドオピエート誘導共役体および標識
JPH01230591A (ja) Ｔ―抗原決定基を有する人工抗原
JPH0231347B2 (enExample)
US7459281B2 (en) Docetaxel immunoassay
JPH0331226B2 (enExample)
US4122078A (en) Antigens and antibodies of catecholamines
US4078049A (en) Acetylcholine assay
US6946547B2 (en) Ecstasy-class analogs and use of same in detection of ecstasy-class compounds
EP0144695A1 (en) Immunogens, antibodies, labeled conjugates, and related derivatives for lidocaine and analogs thereof
JPH0651670B2 (ja) 二官能性ハプテンおよび免疫化学的ハプテン測定法
JP4521029B2 (ja) サイトキサン抗体及びイムノアッセイ
Jones et al. Synthesis of LJP 993, a multivalent conjugate of the N-terminal domain of β2GPI and suppression of an anti-β2GPI immune response
Castro et al. Nicotine antibody production: Comparison of two nicotine conjugates in different animal species
JPH09507841A (ja) プロカインアミドおよびｎａｐａのマレイミド付加物結合体
JPS58216124A (ja) プロプラノロ−ル試験用プロプラノロ−ルイムノゲン及びプロプラノロ−ル化合物並びにそれらを用いる試験法
JP2600325B2 (ja) 抗体、抗体産生細胞および抗体の作製方法
JPS6210070A (ja) ヒスタミン誘導体、免疫原接合体およびそれに対してレイズされた抗体
CA1128883A (en) Flavin adenine dinucleotide - labeled conjugates for use in specific binding assays
SU792869A1 (ru) Способ получени конъюгированных антигенов барбитурова кислота-иммуногенный носитель
US7148024B2 (en) Busulfan immunoassay
JPH0453880B2 (enExample)
US4795828A (en) Functionalized intermediate for the synthesis of alpha-functionalized derivatives and labeled conjugates of procaimamide and NAPA